Intraislet Communication in Surgically-Altered Pancreas

手术改变胰腺的胰岛内通讯

基本信息

  • 批准号:
    7177858
  • 负责人:
  • 金额:
    $ 32.11万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1993
  • 资助国家:
    美国
  • 起止时间:
    1993-05-01 至 2010-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Preliminary data suggest the presence of a delta-to-beta cell endocrine axis within the islet in which intraislet somatostatin inhibits insulin secretion. The somatostatin receptor subtypes responsible for the inhibition of insulin are unknown, however, preliminary data suggest that SSTR1 and SSTR5 are important regulators of insulin secretion and that there are species differences. We have also demonstrated the importance of the axis in that gene ablation of SSTR5 and/or SSTR1 in mice results in significant age- and sex-dependent alterations in insulin secretion, glucose regulation and islet morphology, and ultimately in diabetes. The purpose of this competitive renewal proposal is to prove the hypotheses that a) intraislet somatostatin is an important inhibitory regulator of insulin secretion via SSTR5, b) systemic somatostatin is an important inhibitory regulator of insulin secretion via SSTR1 and c) disruption of the inhibitory effect of intraislet and/or systemic somatostatin by gene ablation of SSTR5 and/or SSTR1 will result in diabetes in mice. We hope to translate the observations in mice to human islets and determine the role of SSTR5 and SSTR1 in the human endocrine pancreas in three specific aims: Specific Aim 1. to determine whether a) intraislet somatostatin inhibits insulin secretion via SSTR5 in mice, b) disruption of the inhibitory effect of intraislet somatostatin by gene ablation of SSTR5 results in altered insulin secretion, glucose homeostasis and islet morphology and ultimately diabetes in older mice and c) the alterations are age- and sex-dependent. Specific Aim 2. to determine whether a) intraislet somatostatin inhibits insulin secretion via SSTR1 in mice, b) disruption of the inhibitory effect of intraislet somatostatin by gene ablation of SSTR1 results in altered insulin secretion, glucose homeostasis and islet morphology and ultimately diabetes in younger mice, and c) the alterations are age- and sex-dependent, and d) double gene ablation of SSTRI/SSTR5 results in altered insulin secretion, glucose homeostasis and islet morphology and ultimately diabetes in mice. Specific Aim 3. to determine whether a) intraislet somatostatin inhibits insulin secretion via SSTR1 and SSTR5 in human islets and b) the regulatory effects of SSTR1 and SSTR5 are age- and sex-dependent. For this proposal, four mouse colonies, already established in our laboratory, will be studied over time: 1) SSTR5 1/- mice, 2) beta cell-specific SSTR5 -/- mice, 3) SSTR1 -/-mice and 4) SSTRI&5 -/- mice. One additional mouse colony will be developed: 1) beta cell-specific SSTR-/- mice. In vivo and in vitro physiology studies will be performed using the following techniques: 1) intraperitoneal glucose tolerance tests in mice 2) isolated perfused mouse pancreas, 3) isolated mouse islet cultures, and 4) isolated perfused human pancreas. The role of SSTR1 and SSTR5 on human and mouse insulin secretion will be determined by examining insulin responses to varying levels of glucose, selective SSTR1 and SSTR5 agonists and to a potent somatostatin monoclonal antibody. Immunohistochemistry, Western blot, Northern blot, Southern blot and RT-PCR will be used to determine whether SSTR1 and SSTR5 gene ablation alters expression of selected regulatory proteins, such as other SSTRs, PDX-1, PCNA, c-Myc, and TGF-beta and Smads in mouse islets. Light microscopy will be used to study alterations in structure of the endocrine pancreas following SSTR1 and SSTR5 gene ablation in mice. The proposed studies will determine whether SSTR1 and SSTR5 are the predominant inhibitory regulators of insulin secretion in human and mouse islets and whether there are pathophysiologic consequences to ablating these receptors in mouse beta cells. Translation of observation in these molecularly-engineered mouse islets to human islets will hopefully provide greater insights into physiologic pathways regulating human insulin secretion, which potentially could benefit in the diagnosis and treatment of patients with diabetes.
描述(由申请人提供): 初步数据表明,胰岛内存在δ-β细胞内分泌轴,其中胰岛内生长抑素抑制胰岛素分泌。负责抑制胰岛素的生长抑素受体亚型是未知的,然而,初步数据表明,SSTR 1和SSTR 5是胰岛素分泌的重要调节因子,并且存在种属差异。我们还证明了轴的重要性,在小鼠中SSTR 5和/或SSTR 1的基因消融导致胰岛素分泌、葡萄糖调节和胰岛形态的显著年龄和性别依赖性改变,并最终导致糖尿病。该竞争性更新提案的目的是证明以下假设:a)胰岛内生长抑素是通过SSTR 5的胰岛素分泌的重要抑制性调节剂,B)全身生长抑素是通过SSTR 1的胰岛素分泌的重要抑制性调节剂,以及c)通过SSTR 5和/或SSTR 1的基因消除破坏胰岛内和/或全身生长抑素的抑制作用将导致小鼠糖尿病。我们希望将小鼠的观察结果转化为人类胰岛,并确定SSTR 5和SSTR 1在人类内分泌胰腺中的作用,具体目标有三个:以确定a)胰岛内生长抑素是否抑制小鼠中通过SSTR 5的胰岛素分泌,B)通过SSTR 5的基因切除破坏胰岛内生长抑素的抑制作用是否导致老年小鼠中胰岛素分泌、葡萄糖稳态和胰岛形态的改变并最终导致糖尿病,以及c)这些改变是否是年龄和性别依赖性的。具体目标2。确定a)胰岛内生长抑素是否抑制小鼠通过SSTR 1的胰岛素分泌,B)通过SSTR 1的基因切除破坏胰岛内生长抑素的抑制作用是否导致胰岛素分泌、葡萄糖稳态和胰岛形态的改变并最终导致年轻小鼠的糖尿病,和c)这些改变是否是年龄和性别依赖性的,和d)SSTR 1/SSTR 5的双基因切除是否导致胰岛素分泌的改变,葡萄糖稳态和胰岛形态,并最终导致小鼠糖尿病。具体目标3。以确定a)胰岛内生长抑素是否通过SSTR 1和SSTR 5抑制人胰岛中的胰岛素分泌,和B)SSTR 1和SSTR 5的调节作用是否是年龄和性别依赖性的。 对于该提议,将随着时间的推移研究已经在我们实验室中建立的四个小鼠集落:1)SSTR 5 1/-小鼠,2)β细胞特异性SSTR 5-/-小鼠,3)SSTR 1-/-小鼠和4)SSTR &5-/-小鼠。将开发另外一个小鼠集落:1)β细胞特异性SSTR-/-小鼠。将使用以下技术进行体内和体外生理学研究:1)小鼠腹膜内葡萄糖耐量试验,2)分离的灌注小鼠胰腺,3)分离的小鼠胰岛培养物,和4)分离的灌注人胰腺。SSTR 1和SSTR 5对人和小鼠胰岛素分泌的作用将通过检查胰岛素对不同水平的葡萄糖、选择性SSTR 1和SSTR 5激动剂和有效的生长抑素单克隆抗体的反应来确定。免疫组织化学、Western印迹、北方印迹、南方印迹和RT-PCR将用于确定SSTR 1和SSTR 5基因去除是否改变小鼠胰岛中所选调节蛋白的表达,所述调节蛋白例如其它SSTR、PDX-1、PCNA、c-Myc和TGF-β和Smads。将使用光学显微镜研究小鼠中SSTR 1和SSTR 5基因消融后内分泌胰腺结构的变化。拟议的研究将确定SSTR 1和SSTR 5是否是人类和小鼠胰岛中胰岛素分泌的主要抑制性调节剂,以及在小鼠β细胞中消融这些受体是否会产生病理生理后果。将这些分子工程小鼠胰岛中的观察结果转化为人类胰岛将有望为调节人类胰岛素分泌的生理途径提供更深入的了解,这可能有助于糖尿病患者的诊断和治疗。

项目成果

期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
PDX-1 is a therapeutic target for pancreatic cancer, insulinoma and islet neoplasia using a novel RNA interference platform.
  • DOI:
    10.1371/journal.pone.0040452
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Liu SH;Rao DD;Nemunaitis J;Senzer N;Zhou G;Dawson D;Gingras MC;Wang Z;Gibbs R;Norman M;Templeton NS;Demayo FJ;O'Malley B;Sanchez R;Fisher WE;Brunicardi FC
  • 通讯作者:
    Brunicardi FC
The effect of global SSTR5 gene ablation on the endocrine pancreas and glucose regulation in aging mice.
整体 SSTR5 基因消融对衰老小鼠内分泌胰腺和葡萄糖调节的影响。
  • DOI:
    10.1016/j.jss.2005.05.024
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Wang,XP;Norman,M;Yang,J;Liu,SH;Magnusson,J;DeMayo,FJ;Brunicardi,FC
  • 通讯作者:
    Brunicardi,FC
Defining the cancer master switch.
定义癌症总开关。
  • DOI:
    10.1007/s00268-010-0941-2
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    2.6
  • 作者:
    Balentine,CourtneyJ;Berger,DavidH;Liu,Shi-He;Chen,Changyi;Nemunaitis,John;Brunicardi,FCharles
  • 通讯作者:
    Brunicardi,FCharles
Double-gene ablation of SSTR1 and SSTR5 results in hyperinsulinemia and improved glucose tolerance in mice.
SSTR1 和 SSTR5 双基因消除导致小鼠高胰岛素血症并改善葡萄糖耐量。
  • DOI:
    10.1016/j.surg.2004.05.042
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Wang,XP;Norman,MA;Yang,J;Cheung,A;Moldovan,S;Demayo,FJ;Brunicardi,FC
  • 通讯作者:
    Brunicardi,FC
Microarray analysis of somatostatin receptor 5-regulated gene expression profiles in murine pancreas.
小鼠胰腺中生长抑素受体 5 调节基因表达谱的微阵列分析。
  • DOI:
    10.1007/s00268-008-9893-1
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    2.6
  • 作者:
    Patel,SanjeetG;Zhou,Guisheng;Liu,Shi-He;Li,Min;Jeong,Jae-Wook;DeMayo,FrancescoJ;Gingras,Marie-Claude;Gibbs,RichardA;Fisher,WilliamE;Brunicardi,FCharles
  • 通讯作者:
    Brunicardi,FCharles
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FRANCIS CHARLES BRUNICARDI其他文献

FRANCIS CHARLES BRUNICARDI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FRANCIS CHARLES BRUNICARDI', 18)}}的其他基金

Somatostatin Receptor Subtype 5 Regulation of Islet Neoplasia
生长抑素受体亚型 5 对胰岛肿瘤的调节
  • 批准号:
    8038523
  • 财政年份:
    2010
  • 资助金额:
    $ 32.11万
  • 项目类别:
Somatostatin Receptor Subtype 5 Regulation of Islet Neoplasia
生长抑素受体亚型 5 对胰岛肿瘤的调节
  • 批准号:
    8627441
  • 财政年份:
    2010
  • 资助金额:
    $ 32.11万
  • 项目类别:
Molecular Surgeon Symposium on Pancreatic Cancer
胰腺癌分子外科医生研讨会
  • 批准号:
    6670370
  • 财政年份:
    2003
  • 资助金额:
    $ 32.11万
  • 项目类别:
PDX-1 is a Therapeutic Target for Pancreatic Cancer
PDX-1是胰腺癌的治疗靶点
  • 批准号:
    7526489
  • 财政年份:
    2002
  • 资助金额:
    $ 32.11万
  • 项目类别:
Pancreatic Cancer Treatment Using Surgery & Gene Therapy
胰腺癌手术治疗
  • 批准号:
    6874950
  • 财政年份:
    2002
  • 资助金额:
    $ 32.11万
  • 项目类别:
PDX-1 is a Therapeutic Target for Pancreatic Cancer
PDX-1是胰腺癌的治疗靶点
  • 批准号:
    8269565
  • 财政年份:
    2002
  • 资助金额:
    $ 32.11万
  • 项目类别:
Pancreatic Cancer Treatment Using Surgery & Gene Therapy
胰腺癌手术治疗
  • 批准号:
    7052122
  • 财政年份:
    2002
  • 资助金额:
    $ 32.11万
  • 项目类别:
Pancreatic Cancer Treatment Using Surgery & Gene Therapy
胰腺癌手术治疗
  • 批准号:
    6623368
  • 财政年份:
    2002
  • 资助金额:
    $ 32.11万
  • 项目类别:
PDX-1 is a Therapeutic Target for Pancreatic Cancer
PDX-1是胰腺癌的治疗靶点
  • 批准号:
    7662493
  • 财政年份:
    2002
  • 资助金额:
    $ 32.11万
  • 项目类别:
PDX-1 is a Therapeutic Target for Pancreatic Cancer
PDX-1是胰腺癌的治疗靶点
  • 批准号:
    7841939
  • 财政年份:
    2002
  • 资助金额:
    $ 32.11万
  • 项目类别:

相似国自然基金

靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
  • 批准号:
    2023JJ50274
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
  • 批准号:
    n/a
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
  • 批准号:
    81602908
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
  • 批准号:
    81501928
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
  • 批准号:
    2341426
  • 财政年份:
    2024
  • 资助金额:
    $ 32.11万
  • 项目类别:
    Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
  • 批准号:
    2341424
  • 财政年份:
    2024
  • 资助金额:
    $ 32.11万
  • 项目类别:
    Continuing Grant
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政​​策的情绪动态
  • 批准号:
    10108433
  • 财政年份:
    2024
  • 资助金额:
    $ 32.11万
  • 项目类别:
    EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
  • 批准号:
    MR/X032809/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.11万
  • 项目类别:
    Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
  • 批准号:
    MR/X034690/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.11万
  • 项目类别:
    Fellowship
Walkability and health-related quality of life in Age-Friendly Cities (AFCs) across Japan and the Asia-Pacific
日本和亚太地区老年友好城市 (AFC) 的步行适宜性和与健康相关的生活质量
  • 批准号:
    24K13490
  • 财政年份:
    2024
  • 资助金额:
    $ 32.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Discovering the (R)Evolution of EurAsian Steppe Metallurgy: Social and environmental impact of the Bronze Age steppes metal-driven economy
发现欧亚草原冶金的(R)演变:青铜时代草原金属驱动型经济的社会和环境影响
  • 批准号:
    EP/Z00022X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.11万
  • 项目类别:
    Research Grant
ICF: Neutrophils and cellular senescence: A vicious circle promoting age-related disease.
ICF:中性粒细胞和细胞衰老:促进与年龄相关疾病的恶性循环。
  • 批准号:
    MR/Y003365/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.11万
  • 项目类别:
    Research Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
  • 批准号:
    2335955
  • 财政年份:
    2024
  • 资助金额:
    $ 32.11万
  • 项目类别:
    Standard Grant
Shaping Competition in the Digital Age (SCiDA) - Principles, tools and institutions of digital regulation in the UK, Germany and the EU
塑造数字时代的竞争 (SCiDA) - 英国、德国和欧盟的数字监管原则、工具和机构
  • 批准号:
    AH/Y007549/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.11万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了